Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05411029 · ClinicalTrials.gov registry record

Study of Disrupted Sleep in Somali Americans

A clinical trial of Healthy and Hypertension, sponsored by Mayo Clinic.

Recruiting
Registry status
240
Enrollment target
1
Study location

NCT05411029: Recruiting study of Healthy and Hypertension, sponsored by Mayo Clinic.

NCT05411029 is a study of Healthy and Hypertension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 240 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05411029, a study of Healthy and Hypertension, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
240 participants
Enrollment target
1
Study location

Study Summary

The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans, and examine the relationship between sleep deficiencies and increased blood pressure in Somali Americans.

Primary Outcome

Number of subjects to have short sleep (\<6 hours) as measured by the sleep study

Interventions

  • DIAGNOSTIC_TEST 24 hour blood pressure (BP) monitoring
  • DIAGNOSTIC_TEST Polysomnography

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2022-11-15
Est. Completion 2031-12
Mayo Clinic

2,844 total trials

What NCT05411029 shows while recruiting

NCT05411029 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (63% lower).

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which 24 hour blood pressure (BP) monitoring is the first listed.

NCT05411029 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05411029 about?

NCT05411029 is a clinical study titled "Study of Disrupted Sleep in Somali Americans". The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans,...

What is the current status of trial NCT05411029?

This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2022-11-15. Estimated completion is 2031-12.

What conditions does trial NCT05411029 study?

This clinical trial studies the following conditions: Healthy, Hypertension, Sleep Disorder.

What interventions are being tested in trial NCT05411029?

The interventions under investigation include: 24 hour blood pressure (BP) monitoring (DIAGNOSTIC_TEST), Polysomnography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05411029?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05411029 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05411029's enrollment target sits among peer trials

240 103rd of 1090 higher than 986 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05411029, the US trial registry maintained by the National Library of Medicine. NCT05411029 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.